Literature DB >> 8372220

Periventricular leukomalacia: correlation between MR imaging and autopsy findings during the first 2 months of life.

E Schouman-Claeys1, M C Henry-Feugeas, F Roset, J C Larroche, D Hassine, J C Sadik, G Frija, J C Gabilan.   

Abstract

PURPOSE: To correlate magnetic resonance (MR) imaging and pathologic findings in premature infants with periventricular leukomalacia (PVL).
MATERIALS AND METHODS: Eight premature infants with PVL who died after 3-7 weeks of life were studied with in vivo T1-weighted MR imaging, and imaging patterns were compared with hypoxic-ischemic injuries at pathologic analysis.
RESULTS: Cavities were seen as zones of absent or weak signal intensity. Translucent sparsely cellular zones appeared as areas of intermediate intensity, and cellular reactions were seen as limited linear or punctate zones of increased intensity, usually less intense than the cortex. MR imaging provided reliable depiction of these lesions, with adequate estimation of their volume and topography. However, the extent of periventricular cellular lesions was underestimated. In one case, blood seen as hyperintense or isointense zones masked portions of cystic lesions, and in three cases small thalamic lesions were overlooked.
CONCLUSION: With the above limitations, T1-weighted MR imaging offers precise evaluation of PVL.

Entities:  

Mesh:

Year:  1993        PMID: 8372220     DOI: 10.1148/radiology.189.1.8372220

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Quantitative Analysis of Punctate White Matter Lesions in Neonates Using Quantitative Susceptibility Mapping and R2* Relaxation.

Authors:  Y Zhang; A Rauscher; C Kames; A M Weber
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-20       Impact factor: 3.825

Review 2.  The instrumented fetal sheep as a model of cerebral white matter injury in the premature infant.

Authors:  Stephen A Back; Art Riddle; Justin Dean; A Roger Hohimer
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 3.  Magnetic resonance imaging in perinatal asphyxia.

Authors:  E Martin; A J Barkovich
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

4.  MR imaging correlates of white-matter pathology in a preterm baboon model.

Authors:  Jennifer L Griffith; Joshua S Shimony; Stephanie A Cousins; Sandra E Rees; Donald C McCurnin; Terrie E Inder; Jeffrey J Neil
Journal:  Pediatr Res       Date:  2011-12-21       Impact factor: 3.756

Review 5.  Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management.

Authors:  Stephen A Back
Journal:  Clin Perinatol       Date:  2014-03       Impact factor: 3.430

6.  From selective vulnerability to connectivity: insights from newborn brain imaging.

Authors:  Steven P Miller; Donna M Ferriero
Journal:  Trends Neurosci       Date:  2009-08-25       Impact factor: 13.837

7.  Magnetic Resonance Imaging in Evaluation of Periventricular Leukomalacia.

Authors:  A Alam; S Sahu
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  White matter injury in the premature infant: a comparison between serial cranial sonographic and MR findings at term.

Authors:  Terrie E Inder; Nigel J Anderson; Carole Spencer; Scott Wells; Joseph J Volpe
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

9.  Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings.

Authors:  Steven P Miller; Camilla Ceppi Cozzio; Ruth B Goldstein; Donna M Ferriero; J Colin Partridge; Daniel B Vigneron; A James Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

10.  Early MR features of hypoxic-ischemic brain injury in neonates with periventricular densities on sonograms.

Authors:  L T Sie; M S van der Knaap; G van Wezel-Meijler; A H Taets van Amerongen; H N Lafeber; J Valk
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.